{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:40:13Z","timestamp":1752550813451},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/beha.2001.0174","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"807-822","source":"Crossref","is-referenced-by-count":18,"title":["Allogeneic transplantation for haemoglobinopathies"],"prefix":"10.1053","volume":"14","author":[{"given":"G","family":"Vassiliou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Amrolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.A.G","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0174_RF1","unstructured":"WHO, 1994, Guidelines for control of haemoglobin disorders. Unpublished document of the WHO"},{"key":"10.1053\/beha.2001.0174_RF2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta-thalassaemia major in the UK: data from the UK thalassaemia register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0174_RF3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons learnt from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nature Review of Genetics"},{"key":"10.1053\/beha.2001.0174_RF4","first-page":"2","article-title":"Outcome of thalassaemia treated with conventional therapy","volume":"19","author":"Borgna-Pignatti","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF5","first-page":"53","article-title":"Survival in b-thalassaemia major: a single centre study","volume":"113","author":"Davis","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF7","series-title":"Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management","first-page":"1052","article-title":"Bone marrow transplantation in b-thalassaemia","author":"Angelucci","year":"2001"},{"key":"10.1053\/beha.2001.0174_RF8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2141.1997.1332948.x","article-title":"Current status of allogeneic transplantation for haemoglobinopathies","volume":"98","author":"Roberts","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199907083410207","article-title":"The beta-thalassemias","volume":"341","author":"Olivieri","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood.V96.10.3357","article-title":"Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia","volume":"96","author":"Reich","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","article-title":"Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin","volume":"406","author":"May","year":"2000","journal-title":"Nature"},{"key":"10.1053\/beha.2001.0174_RF12","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V97.10.3275","article-title":"Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy","volume":"97","author":"Persons","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF13","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.V87.5.2082.2082","article-title":"Marrow transplantation for patients with thalassemia: results in class 3 patients","volume":"87","author":"Lucarelli","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00043426-200011000-00030","article-title":"Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience","volume":"22","author":"Menzer","year":"2000","journal-title":"Journal of Pediatric Hematology and Oncology"},{"key":"10.1053\/beha.2001.0174_RF15","first-page":"33","article-title":"Bone marrow transplantation for b-thalassaemia: experience of two UK centres","volume":"113","author":"Lawson","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF16","first-page":"48","article-title":"The Pescara experience","volume":"19","author":"Di Bartolomeo","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.bmt.1701509","article-title":"Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran","volume":"22","author":"Ghavamzadeh","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF18","first-page":"62","article-title":"Stem cell transplantation for thalassaemia patients in Hong Kong","volume":"19","author":"Li","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bmt.1701814","article-title":"Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing bone marrow transplantation","volume":"24","author":"Poonkuzhali","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0955-3886(00)00103-X","article-title":"Haematopoietic stem cell transplantation for the management of haemoglobinopathies in Greece","volume":"23","author":"Peristeri","year":"2000","journal-title":"Transfusion Science"},{"key":"10.1053\/beha.2001.0174_RF21","first-page":"112","article-title":"Report of the French experience concerning 26 children transplanted for severe sickle cell disease","volume":"19","author":"Bernaudin","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF22","first-page":"559","article-title":"Bone marrow transplantation for thalassaemia: experience of two British centres","volume":"13","author":"Vellodi","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF23","first-page":"60","article-title":"BMT for children with b-thalassaemia major in the UK","volume":"19","author":"Roberts","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF24","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.V80.9.2425.2425","article-title":"Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation","volume":"80","author":"Grochow","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF25","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V79.9.2475.2475","article-title":"Is 600mg\/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?","volume":"79","author":"Vassal","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF26","first-page":"54","article-title":"Bone marrow and cord blood stem cell transplantation for thalassemia in Thailand","volume":"19","author":"Issaragrisil","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF27","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.V80.9.2425.2425","article-title":"Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation","volume":"80","author":"Yeager","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF28","first-page":"31","article-title":"Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics","volume":"16","author":"Slattery","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02931.x","article-title":"Analysis of chimerism in thalassaemic children undergoing stem cell transplantation","volume":"114","author":"Amrolia","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0140-6736(92)91343-7","article-title":"Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia","volume":"339","author":"Angelucci","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0174_RF31","first-page":"59","article-title":"Bone marrow transplantation in Class 2 thalassaemia patients","volume":"19","author":"Giardini","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF32","first-page":"143","article-title":"Mixed chimerism in thalassemic patients after bone marrow transplantation","volume":"10","author":"Nesci","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1702151","article-title":"Long-term survival of ex-thalassaemic patients with persistent mixed chimerism after bone marow transplantation","volume":"25","author":"Andreani","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00043426-199803000-00011","article-title":"Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major","volume":"20","author":"Aker","year":"1998","journal-title":"Journal of Pediatric Hematology and Oncology"},{"key":"10.1053\/beha.2001.0174_RF36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1702076","article-title":"Second marrow transplants for graft failure in patients with thalassemia","volume":"12","author":"Gaziev","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF37","first-page":"56","article-title":"Bone marrow transplantation in Class 1 thalassaemia patients","volume":"19","author":"Baronciani","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00007890-199703270-00011","article-title":"Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors","volume":"63","author":"Gaziev","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/beha.2001.0174_RF39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2141.1995.tb08426.x","article-title":"Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia","volume":"89","author":"Barbanti","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF40","first-page":"123","article-title":"Phlebotomy to reduce iron overload in patients cured of thalassaemia by marrow transplantation","volume":"19","author":"Angelucci","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF41","first-page":"771","volume":"11","year":"1998","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1053\/beha.2001.0174_RF42","first-page":"100","article-title":"Growth in children after bone marrow transplantation for thalassaemia","volume":"12","author":"Gaziev","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF43","first-page":"48","article-title":"Growth and development in ex-thalassaemic patients","volume":"19","author":"de Sanctis","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF44","first-page":"227","article-title":"Growth and endocrine function following bone marrow transplantation for thalassaemia","volume":"15","author":"de Simone","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.66.4.517","article-title":"Gonadal function after allogeneic bone marrow transplantation for thalassaemia","volume":"66","author":"de Sanctis","year":"1991","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beha.2001.0174_RF46","first-page":"235","article-title":"Successful pregnancy after bone marrow transplantation for thalassaemia","volume":"18","author":"Borgna-Pignatti","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF47","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","article-title":"Pregnancies following high dose cyclophosphamide with or without high dose busulfan or total body irradiation and bone marrow transplantation","volume":"87","author":"Sanders","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.1998.16.5.1978","article-title":"Pregnancy after bone marrow transplantation","volume":"16","author":"Gulati","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2001.0174_RF49","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood.V93.4.1164","article-title":"Bone marrow transplantation in adult thalassemic patients","volume":"93","author":"Lucarelli","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/stem.5530040405","article-title":"HLA compatibility for patients with thalassemia: implications for bone marrow transplantation","volume":"4","author":"Delfini","year":"1986","journal-title":"International Journal of Cell Cloning"},{"key":"10.1053\/beha.2001.0174_RF51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bmt.1702242","article-title":"Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants","volume":"25","author":"Gaziev","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF52","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF53","first-page":"200a","article-title":"Influence of preparative regimen and methotrexate GVHD prophylaxis on engraftment after related cord blood transplant for hemoglobinopathies. An Eurocord group analysis","volume":"96","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.V88.2.755.bloodjournal882755","article-title":"Autologuous marrow recovery in a multitransfused beta-thalassemia major patient after umbilical cord blood transplantation","volume":"88","author":"Chik","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF55","first-page":"414a","article-title":"Unrelated donor bone marrow transplantation for thalassemia (preliminary report)","volume":"96","author":"La Nasa","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF56","first-page":"11","article-title":"Mortality and morbidity in thalassaemia with conventional treatment","volume":"19","author":"Piga","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","article-title":"Combined therapy with deferiprone and desferrioxamine","volume":"103","author":"Wonke","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0174_RF58","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF60","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V97.11.3628","article-title":"Five years of experience with hydroxyurea in children and young adults with sickle cell disease","volume":"97","author":"Ferster","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0268-960X(93)90018-Y","article-title":"Bone marrow transplant for sickle cell disease: the dilemma","volume":"7","author":"Davies","year":"1993","journal-title":"Blood Review"},{"key":"10.1053\/beha.2001.0174_RF62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF63","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease","volume":"95","author":"Walters","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","article-title":"Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium","volume":"22","author":"Vermylen","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars","year":"1978","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0174_RF67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF68","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood.V95.10.3057","article-title":"Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis","volume":"95","author":"Nietert","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF69","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF70","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/adc.75.1.3","article-title":"Bone marrow transplant for sickle cell disease \u2013 an update","volume":"75","author":"Davies","year":"1996","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beha.2001.0174_RF72","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia","volume":"2","author":"Walters","year":"1996","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF73","first-page":"112","article-title":"Report of the French experience concerning 26 children transplanted for severe sickle cell disease","volume":"19","author":"Bernaudin","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF74","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V85.4.879.bloodjournal854879","article-title":"Neurologic complications after allogeneic marrow transplantation for sickle cell anemia","volume":"85","author":"Walters","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF75","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1537-2995.2000.40091071.x","article-title":"Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease","volume":"40","author":"Baron","year":"2000","journal-title":"Transfusion"},{"key":"10.1053\/beha.2001.0174_RF76","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","article-title":"Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease","volume":"26","author":"van Besien","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0174_RF77","first-page":"366b","article-title":"Unrelated placental\/umbilical cord blood cell (UCBC) transplantation in children with high-risk sickle cell disease (SCD)","volume":"96","author":"Yeager","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00062752-200103000-00010","article-title":"Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease","volume":"8","author":"Atweh","year":"2001","journal-title":"Current Opinion in Hematology"},{"key":"10.1053\/beha.2001.0174_RF79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V97.5.1451","article-title":"Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease","volume":"97","author":"Bennekou","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF80","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood.V96.4.1239.h8001239_1239_1246","article-title":"Nonmyeloablative stem cell transplantation for congenital immunodeficiencies","volume":"96","author":"Amrolia","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0174_RF81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440119","article-title":"Bone marrow transplantation without myeloablation for sickle cell disease","volume":"344","author":"Krishnamurti","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0174_RF82","first-page":"82","article-title":"Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies","volume":"27","author":"Amado","year":"2000","journal-title":"Seminars in Oncology"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:20:48Z","timestamp":1704320448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1521692601901744"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0174","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}